Rapport Therapeutics Inc (RAPP)
SG&A Expense Growth
-18.32%
Quarterly · Period ending:
RAPP SG&A Expense Growth
Latest reported-18.32%period ending
Latest reported-18.32%period ending
RAPP Quarterly SG&A Growth (QoQ) (0.00% → -18.32%)
Latest values, visible window
High-resolution chart · PNG
RAPP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -18.3233% | |
| 39.3649% | |
| 7.0585% | |
| 13.0722% | |
| -9.5541% | |
| 19.2028% | |
| 3.6903% | |
| 19.2917% | |
| 11.3508% | |
| 53.2554% | |
| 50.9577% | |
| 3.9288% | |
| 47.7554% | |
| 0% |